Echo IQ Limited provides artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia and the United Kingdom. It operates through Houston We Have Software and Echo IQ segments. The company offers EchoSolv, an AI software for identification of aortic stenosis heart condition to physicians and healthcare facilities. It also provides software products and services for the defence and other sectors. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is based in Sydney, Australia.